Progress of non-coding RNAs in triple-negative breast cancer

Siegel, 2020, Cancer statistics, 2020, CA Cancer J. Clin., 70, 7, 10.3322/caac.21590 Zhang, 2019, Transcriptome of 17β-hydroxysteroid dehydrogenase type 2 plays both hormone-dependent and hormone-independent roles in MCF-7 breast cancer cells, J. Steroid Biochem. Mol. Biol., 195, 105471, 10.1016/j.jsbmb.2019.105471 Hon, 2016, Breast cancer molecular subtypes: from TNBC to QNBC, Am. J. Cancer Res., 6, 1864 Palma, 2015, Triple negative breast cancer: looking for the missing link between biology and treatments, Oncotarget, 6, 26560, 10.18632/oncotarget.5306 Mayer, 2014, New strategies for triple-negative breast cancer-deciphering the heterogeneity, Clin. Cancer Res., 20, 782, 10.1158/1078-0432.CCR-13-0583 Lin, 2010, Molecular therapy of breast cancer: Progress and future directions, Nat. Rev. Endocrinol., 6, 485, 10.1038/nrendo.2010.92 Yang, 2020, Recent treatment progress of triple negative breast cancer, Prog. Biophys. Mol. Biol., 151, 40, 10.1016/j.pbiomolbio.2019.11.007 Silva, 2019, Long noncoding RNAs: a missing link in osteoporosis, Bone Res, 7, 10.1038/s41413-019-0048-9 Anastasiadou, 2017, Non-coding RNA networks in cancer, Nat. Rev. Cancer, 18, 5, 10.1038/nrc.2017.99 Merrill, 2020, Molecular determinants of drug response in TNBC cell lines, Breast Cancer Res. Treat., 179, 337, 10.1007/s10549-019-05473-9 Lu, 2018, MicroRNA, J. Allergy Clin. Immunol., 141, 1202, 10.1016/j.jaci.2017.08.034 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Chen, 2018, MiR-137 suppresses triple-negative breast cancer stemness and tumorigenesis by perturbing BCL11A-DNMT1 interaction, Cell. Physiol. Biochem., 47, 2147, 10.1159/000491526 Chu, 2018, MiR-4319 suppress the malignancy of triple-negative breast cancer by regulating self-renewal and tumorigenesis of stem cells, Cell. Physiol. Biochem., 48, 593, 10.1159/000491888 Mayoral-Varo, 2017, miR205 inhibits stem cell renewal in SUM159PT breast cancer cells, PLoS One, 12, 10.1371/journal.pone.0188637 Tan, 2014, miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer, Breast Cancer Res., 16, 10.1186/s13058-014-0435-5 Kong, 2014, Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer, Oncogene, 33, 679, 10.1038/onc.2012.636 Ren, 2015, MiR-27a modulates radiosensitivity of triple- negative breast cancer (TNBC) cells by targeting CDC27, Med. Sci. Monit., 21, 1297, 10.12659/MSM.893974 Wu, 2018, MicroRNA-27a promotes tumorigenesis via targeting AKT in triple negative breast cancer, Mol. Med. Rep., 17, 562 Wang, 2018, MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1, Oncol. Rep., 39, 2563 Jin, 2015, Non-specific blocking of MIR-17-5p guide strand in triple negative breast cancer cells by amplifying passenger strand activity, PLoS One, 10, 10.1371/journal.pone.0142574 Li, 2017, miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer, BMC Cancer, 17, 10.1186/s12885-017-3674-x Xiao, 2018, MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer, Br. J. Surg., 105, 75, 10.1002/bjs.10646 Jia, 2016, KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2, Oncogene, 35, 2040, 10.1038/onc.2015.263 Zeng, 2019, MicroRNA-135b alleviates MPP+-mediated Parkinson’s disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis, J. Clin. Neurosci., 65, 125, 10.1016/j.jocn.2019.04.004 Uva, 2018, miRNA-135b contributes to triple negative breast cancer molecular heterogeneity: different expression profile in basal-like versus non-basal-like phenotypes, Int. J. Med. Sci., 15, 536, 10.7150/ijms.23402 Toda, 2018, Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3, J. Hum. Genet., 63, 1197, 10.1038/s10038-018-0510-3 Li, 2017, miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer, Breast Cancer Res., 19, 10.1186/s13058-017-0918-2 Mohammadi Yeganeh, 2017, The effect of miR-340 over-expression on cell-cycle–related genes in triple-negative breast cancer cells, Eur. J. Cancer Care (Engl)., 26, 10.1111/ecc.12496 Song, 2015, MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells’ growth and migration, Tumor Biol., 36, 5001, 10.1007/s13277-015-3151-6 Tang, 2014, miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer, Mol. Cancer Ther., 13, 3185, 10.1158/1535-7163.MCT-14-0243 Li, 2017, MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24, Oncotarget, 8, 19455, 10.18632/oncotarget.14307 Humphries, 2017, ARHGAP18 downregulation by miR-200b suppresses metastasis of triple-negative breast cancer by enhancing activation of RhoA, Cancer Res., 77, 4051, 10.1158/0008-5472.CAN-16-3141 Wang, 2018, miR-30a inhibits epithelial-mesenchymal transition and metastasis in triple-negative breast cancer by targeting ROR1, Oncol. Rep., 39, 2635 Wu, 2017, Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells, Biochem. Biophys. Res. Commun., 483, 10, 10.1016/j.bbrc.2017.01.023 Kim, 2018, IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor, Cancer Lett., 415, 30, 10.1016/j.canlet.2017.11.039 Xiong, 2017, miR-103 regulates triple negative breast cancer cells migration and invasion through targeting olfactomedin 4, Biomed. Pharmacother., 89, 1401, 10.1016/j.biopha.2017.02.028 Wu, 2018, EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer, Acta Biochim. Biophys. Sin. Shanghai, 50, 693, 10.1093/abbs/gmy050 Chen, 2018, microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1, J. Cell. Biochem., 119, 4945, 10.1002/jcb.26739 Zeng, 2017, Low expression of circulating microRNA-34c is associated with poor prognosis in triple-negative breast cancer, Yonsei Med. J., 58, 697, 10.3349/ymj.2017.58.4.697 Adams, 2016, MiR-34a silences c-SRC to attenuate tumor growth in triple-negative breast cancer, Cancer Res., 76, 927, 10.1158/0008-5472.CAN-15-2321 Bayraktar, 2018, Dual suppressive effect of miR-34A on the FOXM1/EEF2-kinase axis regulates triple-negative breast cancer growth and invasion, Clin. Cancer Res., 24, 4225, 10.1158/1078-0432.CCR-17-1959 Lv, 2018, MiR-212-5p suppresses the epithelial-mesenchymal transition in triple-negative breast cancer by targeting PRRX2, Cell. Physiol. Biochem., 44, 1785, 10.1159/000485785 Wang, 2017, miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer, Breast Cancer Res., 19, 10.1186/s13058-017-0865-y Fkih M’hamed, 2015, Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers, Cell. Oncol., 38, 433, 10.1007/s13402-015-0239-3 Rhodes, 2015, Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer, Oncotarget, 6, 16638, 10.18632/oncotarget.3184 Liu, 2015, MiR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer, Cancer Lett., 357, 384, 10.1016/j.canlet.2014.11.050 Liu, 2015, MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triplenegative breast cancer, Oncotarget, 6, 20070, 10.18632/oncotarget.4039 Bai, 2018, MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3, Biomed. Pharmacother., 103, 1482, 10.1016/j.biopha.2018.04.165 Song, 2018, MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD, BMB Rep., 51, 602, 10.5483/BMBRep.2018.51.11.168 Mohammadi-Yeganeh, 2015, Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer, Chem. Biol. Drug Des., 86, 1185, 10.1111/cbdd.12584 Ren, 2014, MicroRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells, Mol. Med. Rep., 10, 315, 10.3892/mmr.2014.2222 Tabassum, 2015, Tumorigenesis: it takes a village, Nat. Rev. Cancer, 15, 473, 10.1038/nrc3971 Bauer, 2015, Hemoglobin switching’s surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin, Curr. Opin. Genet. Dev., 33, 62, 10.1016/j.gde.2015.08.001 Li, 2015, Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis, Cell Cycle, 14, 146, 10.4161/15384101.2014.967106 Chang, 2014, Molecular architecture and mechanism of the anaphase-promoting complex, Nature, 513, 388, 10.1038/nature13543 Gong, 2016, Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation, Neuro-Oncology, 18, 48, 10.1093/neuonc/nov096 De Yébenes, 2014, MiR-217 is an oncogene that enhances the germinal center reaction, Blood, 124, 229, 10.1182/blood-2013-12-543611 Su, 2014, miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3, Mol. Cell. Biochem., 392, 289, 10.1007/s11010-014-2039-x Zhou, 2017, MIR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5, PLoS One, 12 Toda, 2018, Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3, J. Hum. Genet., 63, 1197, 10.1038/s10038-018-0510-3 Chaffer, 2011, A perspective on cancer cell metastasis, Science, 331, 1559, 10.1126/science.1203543 Lawson, 2014, The on-off relationship of RHO and RAC during integrin-mediated adhesion and cell migration, Small GTPases, 5, 10.4161/sgtp.27958 Tao, 2016, MicroRNA-34c suppresses breast cancer migration and invasion by targeting GIT1, J. Cancer, 7, 1653, 10.7150/jca.14762 Wang, 2018, miR-30a inhibits epithelial-mesenchymal transition and metastasis in triple-negative breast cancer by targeting ROR1, Oncol. Rep., 39, 2635 Balakrishnan, 2017, Analysis of ROR1 protein expression in human cancer and normal tissues, Clin. Cancer Res., 23, 3061, 10.1158/1078-0432.CCR-16-2083 Wu, 2017, Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells, Biochem. Biophys. Res. Commun., 483, 10, 10.1016/j.bbrc.2017.01.023 Xiao, 2017, MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression, J. Cancer Res. Clin. Oncol., 143, 263, 10.1007/s00432-016-2280-7 Yang, 2017, miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway, Inflamm. Res., 66, 341, 10.1007/s00011-016-1020-4 Yang, 2017, miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9, Cell Death Dis., 8, e2999, 10.1038/cddis.2017.356 Li, 2013, MiR-139 inhibits MCL-1 expression and potentiates TMZ-induced apoptosis in glioma, CNS Neurosci. Ther., 19, 477, 10.1111/cns.12089 Liu, 2015, MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triplenegative breast cancer, Oncotarget, 6, 20070, 10.18632/oncotarget.4039 Li, 2016, MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells, Life Sci., 147, 143, 10.1016/j.lfs.2016.01.044 Zhu, 2013, Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer, Am. J. Cancer Res., 3, 230 Jang, 2017, Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer, Hum. Pathol., 68, 69, 10.1016/j.humpath.2017.08.026 Xu, 2017, Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer, Biomed. Pharmacother., 96, 14, 10.1016/j.biopha.2017.09.107 Wu, 2018, Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer, Biomed. Pharmacother., 97, 1275, 10.1016/j.biopha.2017.11.055 Wang, 2018, LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci, Cell Death Dis., 9 Tang, 2018, Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer, Biomed. Pharmacother., 107, 338, 10.1016/j.biopha.2018.07.076 Wang, 2018, Long non-coding RNA (lncRNA) RMST in triple-negative breast cancer (TNBC): expression analysis and biological roles research, J. Cell. Physiol., 233, 6603, 10.1002/jcp.26311 Wang, 2017, C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer, Am. J. Transl. Res., 9, 533 Tao, 2018, Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis, Biochem. Biophys. Res. Commun., 504, 629, 10.1016/j.bbrc.2018.08.122 Zuo, 2017, Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer, Biomed. Pharmacother., 95, 922, 10.1016/j.biopha.2017.09.005 Sha, 2017, Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression, Biol. Open., 6, 1310 Ma, 2018, LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1, Biochem. Biophys. Res. Commun., 500, 614, 10.1016/j.bbrc.2018.04.119 Liu, 2017, Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling, Pharmazie, 72, 599 Wang, 2018, A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer, Oncogene, 37, 4662, 10.1038/s41388-018-0293-1 Yang, 2018, An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer, Cell Death Differ., 25, 2209, 10.1038/s41418-018-0123-6 Zhao, 2016, LncRNA taurine-upregulated gene 1 promotes cell proliferation by inhibiting microRNA-9 in MCF-7 cells, J. Breast Cancer, 19, 349, 10.4048/jbc.2016.19.4.349 Zhai, 2015, Microarray expression profile of lncRNAs and the upregulated ASLNC04080 lncRNA in human endometrial carcinoma, Int. J. Oncol., 46, 2125, 10.3892/ijo.2015.2897 Liu, 2020, Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer, J. Cell. Biochem., 121, 2756, 10.1002/jcb.29515 Dustin, 2019, ESR1 mutations in breast cancer, Cancer, 125, 3714, 10.1002/cncr.32345 Wang, 2018, A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer, Oncogene, 37, 4662, 10.1038/s41388-018-0293-1 Chen, 2018, Circepsti1 as a prognostic marker and mediator of triple-negative breast cancer progression, Theranostics, 8, 4003, 10.7150/thno.24106 He, 2017, CircGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a, J. Exp. Clin. Cancer Res., 36, 10.1186/s13046-017-0614-1 Wang, 2018, Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway, Biochem. Biophys. Res. Commun., 505, 996, 10.1016/j.bbrc.2018.10.026 Zheng, 2020, The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer, Mol. Cancer, 19, 10.1186/s12943-020-01183-9 Yang, 2019, The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression, Mol. Cancer, 18, 4, 10.1186/s12943-018-0933-7 Zeng, 2018, The pro-metastasis effect of circANKS1B in breast cancer, Mol. Cancer, 17, 160, 10.1186/s12943-018-0914-x Ye, 2019, circFBXW7 inhibits malignant progression by sponging miR-197-3p and encoding a 185-aa protein in triple-negative breast Cancer, Mol. Ther. - Nucleic Acids., 18, 88, 10.1016/j.omtn.2019.07.023 Liu, 2020, circGNB1 facilitates triple-negative breast cancer progression by regulating miR-141-5p-IGF1R Axis, Front. Genet., 11, 193, 10.3389/fgene.2020.00193 Kong, 2019, CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression, Epigenomics, 11, 1163, 10.2217/epi-2019-0093 Pei, 2020, Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448, Int. J. Biochem. Cell Biol., 126, 10.1016/j.biocel.2020.105798 Dou, 2020, CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis, Cancer Cell Int., 20, 10.1186/s12935-020-01547-7 Zou, 2019, circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression, Carcinogenesis, 40, 1469 He, 2020, The novel circular rna circ-pgap3 promotes the proliferation and invasion of triple negative breast cancer by regulating the mir-330-3p/myc axis, Onco. Targets. Ther., 13, 10149, 10.2147/OTT.S274574 Sang, 2018, Circular RNA ciRS-7 maintains metastatic phenotypes as a ceRNA of miR-1299 to target MMPs, Mol. Cancer Res., 16, 1665, 10.1158/1541-7786.MCR-18-0284 Hu, 2020, Hsa_circ_0091074 regulates TAZ expression via microRNA–1297 in triple negative breast cancer cells, Int. J. Oncol., 56, 1314 Li, 2013, MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1, Clin. Exp. Med., 13, 109, 10.1007/s10238-012-0186-5 Matsui, 2017, Non-coding RNAs as drug targets, Nat. Rev. Drug Discov., 16, 167, 10.1038/nrd.2016.117 Janssen, 2013, HCV infection and miravirsen, N. Engl. J. Med., 369, 877, 10.1056/NEJMc1307787 van der Ree, 2017, Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial, Lancet, 389, 709, 10.1016/S0140-6736(16)31715-9 Hanna, 2012, Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer, Cancer Gene Ther., 19, 374, 10.1038/cgt.2012.10 Hong, 2020, Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours, Br. J. Cancer, 122, 1630, 10.1038/s41416-020-0802-1